TG Therapeutics, Inc.
TGTXBiotechnology
$61.18+5.34%As of Oct 30vs prior close
- Market cap
- $9.4B
- P/E (TTM)
- 21.2×
- From 52W high
- 0.00%
- EPS (LTM)
- $2.74
- Revenue (LTM)
- $799.5M
- Net margin
- 55.22%
- Dividend yield
- 0.00%
Nomior Score
68
Steady ProfileTop 12% of the scored universe
Growth56
Quality73
Value50
Momentum83
Resilience46
Growth
+151.70%revenue a year over 9 fiscal years
FY16 $152KLTM $799.5M
Connections
Revenue to profitQ2 FY26
3% of revenue became net profit, down 17 pts on a year.
Who owns it
2funds